Hiatt WR, Goldstone J, Smith SC Jr, McDermott M, Moneta G, Oka R, et al.;American Heart Association Writing Group 1. Atherosclerotic Peripheral Vascular Disease Symposium II: nomenclature for vascular diseases. Circulation 2008; 118: 2826-9.
Selvin E, Erlinger TP. Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000. Circulation 2004; 110: 738-43.
Fowkes FG, Rudan D, Rudan I, Aboyans V, Denenberg JO, McDermott MM, et al. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet 2013; 382: 1329-40.
Newman AB, Siscovick DS, Manolio TA, Polak J, Fried LP, Borhani NO, et al. Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study. Cardiovascular Heart Study (CHS) Collaborative Research Group. Circulation 1993; 88: 837-45.
Feig DI, Kang DH, Johnson RJ. Uric acid and cardiovascular risk. N Engl J Med 2008; 359: 1811-21.
Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG;TASC II Working Group. Inter-society consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg 2007; 45 Suppl S: S5-67
Berry CE, Hare JM. Xanthine oxidoreductase and cardiovascular disease:molecular mechanisms and pathophysiological implications. J Physiol 2004;555: 589-606.
Baker JF, Schumacher HR, Krishnan E. Serum uric acid level and risk for peripheral arterial disease: analysis of data from the multiple risk factor intervention trial. Angiology 2007; 58: 450-7.
Zhan Y, Dong Y, Tang Z, Zhang F, Hu D, Yu J. Serum uric acid, gender, and low ankle brachial index in adults with high cardiovascular risk. Angiology 2015; 66: 687-91.
Shankar A, Klein BE, Nieto FJ, Klein R. Association between serum uric acid level and peripheral arterial disease. Atherosclerosis 2008; 196: 749-55.
Sotoda Y, Hirooka S, Orita H, Wakabayashi I. Association of serum uric acid levels with leg ischemia in patients with peripheral arterial disease after treatment. J Atheroscler Thromb 2017; 24: 725-34.
Johnson RJ, Kang DH, Feig D, Kivlighn S, Kanellis J, Watanabe S, et al. Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension 2003; 41: 1183-90.
Fang J, Alderman MH. Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971-1992. National Health and Nutrition Examination Survey. JAMA 2000; 283: 2404-10.
Alderman MH, Cohen H, Madhavan S, Kivlighn S. Serum uric acid and cardiovascular events in successfully treated hypertensive patients. Hypertension 1999; 34: 144-50.
Lee WS, Kang TS, Lee YH, Han MK. Assessment of association between metabolic syndrome and serum uric acid level in subjects who visited the health promotion center. Korean J Fam Pract 2017; 7: 207-12.
Kim HY, Baek SH, Kim MJ, Park KS, Kim YS, Oh MJ, et al. Relationships between serum uric acid level and coronary artery calcium score. Korean J Fam Pract 2015; 5: 198-203.
Choi NY, Koh HM, Lee JH. Association of serum uric acid level with risk factors of cardiovascular disease and coronary artery calcium score. Korean J Fam Pract 2016; 6: 215-20.
Battelli MG, Polito L, Bolognesi A. Xanthine oxidoreductase in atherosclerosis pathogenesis: not only oxidative stress. Atherosclerosis 2014; 237: 562-7.
McKenna M, Wolfson S, Kuller L. The ratio of ankle and arm arterial pressure as an independent predictor of mortality. Atherosclerosis 1991; 87: 119-28.
Li Y, Lu J, Wu X, Yang C. Serum uric acid concentration and asymptomatic hyperuricemia with subclinical organ damage in general population. Angiology 2014; 65: 634-40.
Rac-Albu M, Iliuta L, Guberna SM, Sinescu C. The role of ankle-brachial index for predicting peripheral arterial disease. Maedica (Buchar) 2014; 9:295-302.
Hirsch AT, Criqui MH, Treat-Jacobson D, Regensteiner JG, Creager MA, Olin JW, et al. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA 2001; 286: 1317-24.
Haugen S, Casserly IP, Regensteiner JG, Hiatt WR. Risk assessment in the patient with established peripheral arterial disease. Vasc Med 2007; 12: 343-50.